Systemic lupus erythematosus
著者
書誌事項
Systemic lupus erythematosus
(A companion to rheumatology)
Mosby, c2007
1st ed
大学図書館所蔵 全3件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
This new companion to Hochberg et al.'s Rheumatology masterwork provides new insights into the causes, detection and therapy of this challenging disease. In this state-of-the-art resource, you'll find 'one stop' coverage of all the latest scientific and clinical developments in SLE: new concepts in epidemiology, disease activity measures and outcomes; new concepts in immunoregulation, genetic and pathogenic mechanisms; new understanding and novel presentation of the processes of tissue/organ damage; comprehensive coverage of clinical features; and the very latest concepts in treatment.
Provides the very latest understanding of the pathogenesis of SLE.
Distills current understanding of the cellular, molecular, genetic and environmental factors that instigate and drive the disease.
Includes comprehensive coverage of clinical features, including fatigue, organ system manifestations, overlap syndromes, infections, and more.
Conveys the very latest understanding of mechanisms of tissue damage, including immune complexes, antibodies, and other mechanisms that lead to organ damage.
Contains expert discussion of processes that are responsible for tissue injury - a hallmark of this text.
Incorporates the latest treatment modalities, including steroids and non-steroidals, cytotoxic drug treatment, PAP's, and therapies on the horizon.
Discusses the latest treatment options on disease modifying or disease controlling agents.
目次
Epidemiology and Diagnosis
1. Epidemiology
2. Disease Activity Measures
3. Disease Outcome
4. Quality of Life and Economic Aspects
Pathogenesis
1. Overview of the Pathogenesis of SLE
2. Genetics
3. Hormones
4. Immunoregulation - T Cells, B cells, and cytokines.
5. Cell Surface Receptors ostimulation/BAFF/FcgR/TLRs)
6. Dendritic Cells
7. Apoptosis
8. Structure and Origin of Autoantibodies
9. Animal Models
10. Genetics of murine lupus
11. Infection and autoimmunity
Mechanisms of Tissue Damage
1. Complement
2. Immune complexes
3. Antibodies
a. ANA and standardization of antibody techniques
b. Anti-DNA
c. Anti-splicesomosal ab
d. Anti-Ro/La
e. Anti-Histone
f. APL
g. Anti-neuronal
4. PMNs
5. Mechanisms of renal damage
6. Mechanisms of vascular damage
7. Nitric Oxide
Clinical Aspects of the Disease
1. Constitutional Symptoms and Fatigue
2. Skin
3. Kidney
4. Heart
5. Lung
6. GI/liver/pancreas
7. Infections
8. Blood (anti-phospholipid syndrome)
9. Nervous System
10. Overlap Syndromes
11. Ophthalmic Manifestations
12. Pregnancy
13. Fertility
14. Neo-natal lupus
15. Hereditary and Malignant Lupus-like Diseases
Treatment of the Disease
1. Non-Steroidals - Anti-Malarials and Statins
2. Steroid Treatment
3. Cytotoxic Drug Treatment including M.M.F
4. PAPS
5. New Treatments
「Nielsen BookData」 より